Yahoo Finance

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

New York, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by ...
The Globe and Mail

Type 1 Diabetes Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s, “Type 1 Diabetes Pipeline Insight, 2025” report provides comprehensive insights about 85+ companies and 100+ pipeline drugs in Type 1 Diabetes pipeline landscape. It covers the Type 1 ...
Mena FN

Diabetes Pipeline Report 2025: Promising Drugs And MOA Innovations Reshape Future Treatment Approaches Delveinsight

DelveInsight's“ Diabetes Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the Diabetes pipeline ...
Business Wire

Insulin Resistance - Pipeline Review, H2 2019 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Insulin Resistance - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Insulin ...
Yahoo Finance

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

New York, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) Drugs in ...